B1-derived IgM or IgA autoantibodies could enter normal CNSs via transcytosis from CNS ventricles where B1 B cells reside or could enter CNSs from blood vessels during pathological conditions such as TBI, MS, AD, or epilepsy when the BBB becomes compromised. Here, CD40LG is linked to epilepsy.